Globe Life (GL) CEO Frank Svoboda Sells 10,000 Shares

Globe Life CEO Frank Svoboda Trades 10,000 Shares

Globe Life Inc. (NYSE: GL) Co-Chairman and CEO Frank Svoboda executed transactions involving 10,000 shares on June 12, 2026. Executive stock sales do not carry inherent bearish signals, as leaders frequently adjust personal portfolios for estate planning or diversification reasons.

Where Globe Life Stock Stands Today

Trading near $167.39, Globe Life shares sit well above their 52-week low of $127.85 and below the 52-week high of $191.55. The company carries a price-to-earnings ratio of 11.4 and a forward P/E of 10.4. With the next earnings report scheduled for October 21, 2026, investors continue to monitor valuation metrics and broader financial sector momentum.

Recent Insider Activity Across Executive Ranks

Executive transactions at Globe Life have kept a steady pace recently. On June 30, 2026, EVP and Chief Administrative Officer Dolores Skarjune bought 1,850 shares at $103.23 for $190,975.50 and sold 1,850 shares at $179.18 for $331,483.00. Earlier, on June 18, 2026, EVP and Chief Talent Officer Rebecca Zorn purchased 2,000 shares at $98.32 for $196,640.00 and sold 2,000 shares. CEO Frank Svoboda also bought 10,000 shares at $100.74 for $1,007,400.00 on June 11, 2026, a day before executing a 10,000-share transaction.

Analysts Set New Price Targets

Wall Street firms maintain positive outlooks on Globe Life. On October 15, 2026, JP Morgan maintained its Overweight rating and raised its price target to $195.00 from $193.00. Wells Fargo maintained an Overweight rating on October 12, 2026, moving its target to $191.00 from $190.00. Morgan Stanley kept its Overweight rating on October 5, 2026, adjusting its target to $197.00 from $208.00. Across 11 analyst opinions, the stock holds a mean price target of $193.91.

Life and Supplemental Health Coverage Provider

Globe Life provides life and supplemental health insurance products targeted at lower-middle and middle-income families across the United States. Operating through life, supplemental health, and investment segments, the company distributes whole and term life policies along with Medicare supplements and accident coverage through direct channels, exclusive agents, and independent brokers.

What to Watch Next for Globe Life

Investors will look toward the upcoming October earnings release for updated revenue and net income figures. Regulatory filings will continue to track whether executives make further adjustments to their equity positions as the year progresses.